---
title: "EHealth outlines 20% fixed cost reduction and targets 20% adjusted EBITDA margin by 2028 as it rolls out lifetime advisory model"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285501207.md"
description: "EHealth outlines 20% fixed cost reduction and targets 20% adjusted EBITDA margin by 2028 as it rolls out lifetime advisory model"
datetime: "2026-05-07T07:12:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285501207.md)
  - [en](https://longbridge.com/en/news/285501207.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285501207.md)
generator: "portal-rs"
---

# EHealth outlines 20% fixed cost reduction and targets 20% adjusted EBITDA margin by 2028 as it rolls out lifetime advisory model


### Related Stocks

- [EHTH.US](https://longbridge.com/en/quote/EHTH.US.md)

## Related News & Research

- [CXT: Aims for ~$2.5B revenue and mid-20s% EBITDA margin by 2028, leveraging tech and M&A](https://longbridge.com/en/news/298595216.md)
- [Descartes Systems reports Q2 adjusted EBITDA $94.4M vs. $80.2M last year](https://longbridge.com/en/news/298678360.md)
- [Omada Health targets at least 20% annual revenue growth, 30% adjusted EBITDA margin long term](https://longbridge.com/en/news/298600874.md)
- [BEC: Net profit up 8% YoY and EBITDA margin near 20%, with strong cash flow and resilient margins](https://longbridge.com/en/news/298626055.md)
- [MIDD: Focused execution on innovation and operational excellence targets double-digit EPS growth by 2028](https://longbridge.com/en/news/298582945.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**